Leuprolide acetate‐induced leukocytoclastic vasculitis
Makaleler > Tam Makale · 2007
Yazarlar: Bengu Gerceker Turk, TUĞRUL DERELİ, Didem DERELİ, Taner AKALIN
Acta Obstetricia et Gynecologica Scandinavica, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2007, cilt 86, ss 892-893
DOI: 10.1080/00016340600608717
Özet
Leukocytoclastic vasculitis (LCV) is a distinct clinicopathological entity with cutaneous lesions from purpuric macules to necrotic ulcers, and the other systemic manifestations, such as fever, arthritis, gastrointestinal complaints, renal failure, etc.Although the exact cause cannot be established in more than half of the cases, various infections, connective tissue disorders, malignancies, cryoglobulinemia, and certain drugs are implicated (1).Leuprolide acetate is a synthetic analog of gonadotropin-releasing hormone that is used in the treatment of endo-metriosis, leiomyomas, and in the palliative treatment of advanced prostatic cancer.Adverse cutaneous reactions rarely occur with leuprolide acetate treatment (2).However, LCV associated with leuprolide acetate has not been reported until now.Here, a leuprolide acetate-induced LCV in a patient who had been treated for endometriosis by leuprolide acetate is presented.